SS
ANIK icon

SBI Securities’s Anika Therapeutics ANIK Stock Holding History

SBI Securities’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102 Hold
7
– – ﹤0.01% 3504
2026
Q1 		$102 Buy
7
+1
+17% +$12 ﹤0.01% 3401
2025
Q4 		$58 Sell
6
-2
-25% -$19 ﹤0.01% 3546
2025
Q3 		$75 Buy
8
+2
+33% +$19 ﹤0.01% 3600
2025
Q2 		$63 Hold
6
– – ﹤0.01% 3668
2025
Q1 		$90 Buy
6
+3
+100% +$50 ﹤0.01% 3474
2024
Q4 		$49 Buy
+3
New +$59 ﹤0.01% 3647

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

SBI Securities's ANIK Position: Q2 2026 in Review

SBI Securities held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 7 shares worth $102. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

SBI Securities first reported a position in ANIK in Q4 2024 and has held it in 7 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • SBI Securities held 7 shares of Anika Therapeutics worth $102 as of Q2 2026.
  • SBI Securities left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3504 holding.
  • SBI Securities first reported a position in Anika Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.